![Fabrice Plasson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabrice Plasson
Presidente en Amoeba US Corp. .
Cargos activos de Fabrice Plasson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amoeba US Corp. | Presidente | - | - |
Entreprise Amoeba Canada, Inc. | Presidente | - | - |
Historial de carrera de Fabrice Plasson
Antiguos cargos conocidos de Fabrice Plasson.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMOÉBA | Director/Miembro de la Junta | - | - |
Director Ejecutivo | 21/07/2010 | 14/12/2023 | |
Presidente | - | 14/12/2023 | |
Fundador | 21/07/2010 | 14/12/2023 | |
Presidente | 21/07/2010 | - | |
EUROFINS DISCOVERX PRODUCTS FRANCE
![]() EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Director Ejecutivo | - | - |
Fundador | - | - | |
Whatman Ltd. | Corporate Officer/Principal | - | - |
Eurofins DiscoverX Corp., Inc.
![]() Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Director/Miembro de la Junta | - | - |
Fundador | - | - | |
Corporate Officer/Principal | - | - |
Formación de Fabrice Plasson.
EM Lyon Business School | Masters Business Admin |
Université Joseph Fourier | Graduate Degree |
Estadísticas
Internacional
Francia | 6 |
Estados Unidos | 3 |
Canadá | 2 |
Operativa
Chairman | 3 |
Founder | 3 |
Director/Board Member | 2 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Consumer Non-Durables | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Empresas privadas | 5 |
---|---|
Eurofins DiscoverX Corp., Inc.
![]() Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Whatman Ltd. | |
Amoeba US Corp. | |
Entreprise Amoeba Canada, Inc. | |
EUROFINS DISCOVERX PRODUCTS FRANCE
![]() EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Commercial Services |
- Bolsa de valores
- Insiders
- Fabrice Plasson
- Experiencia